BEDROSIAN CAMILLE L (Chief Medical Officer) sold 3.7% of their position (6.46K shares) of AMYLYX PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $94.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2026ACC: 0001193125-26-091440
Officer· Chief Medical Officer
Since Mar 2026
-6.46K
Net shares
Net seller
$94.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.46K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.46K
Price / share
$14.58
Trade value
$94.21K
% of position
3.7%
3/2/2026
175.76K→169.29K
Total
Net shares
−6.46K
Net value
-$94.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −6.46K | $14.58 | $94.21K | 3.7% | 175.76K | 169.29K |
| Total | −6.46K | -$94.21K | ||||||
Derivative Transactions0
No derivative transactions reported